Abeona Therapeutics Inc. financial data

Symbol
ABEO on Nasdaq
Industry
Pharmaceutical Preparations
Location
6555 Carnegie Ave, 4 Th Floor, Cleveland, OH
State of incorporation
DE
Fiscal year end
December 31
Former names
PLASMATECH BIOPHARMACEUTICALS INC (to 6/4/2015), ACCESS PHARMACEUTICALS INC (to 8/14/2014), CHEMEX PHARMACEUTICALS INC (to 2/5/1996)
Latest financial report
10-Q - Q2 2024 - Aug 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 604 % +36%
Debt-to-equity 235 % +13.1%
Return On Equity -208 % +11.1%
Return On Assets -62.1 % +17.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.3M shares +75%
Common Stock, Shares, Outstanding 41.7M shares +94%
Entity Public Float 78.5M USD +173%
Common Stock, Value, Issued 417K USD +94%
Weighted Average Number of Shares Outstanding, Basic 40M shares +122%
Weighted Average Number of Shares Outstanding, Diluted 51.2M shares +184%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 3.5M USD +250%
Research and Development Expense 31M USD +9.27%
General and Administrative Expense 25.8M USD +38.5%
Operating Income (Loss) -56.7M USD -26.3%
Nonoperating Income (Expense) 711K USD -89.9%
Net Income (Loss) Attributable to Parent -52.6M USD -33.8%
Earnings Per Share, Basic -2.04 USD/shares +55.2%
Earnings Per Share, Diluted -2.49 USD/shares +71.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 34.4M USD +453%
Cash, Cash Equivalents, and Short-term Investments 123M USD +232%
Accounts Receivable, after Allowance for Credit Loss, Current 3.5M USD +250%
Assets, Current 126M USD +186%
Property, Plant and Equipment, Net 3.98M USD -11.5%
Operating Lease, Right-of-Use Asset 4.02M USD -18.1%
Other Assets, Noncurrent 100K USD
Assets 134M USD +150%
Accounts Payable, Current 3.1M USD -10.9%
Accrued Liabilities, Current 4.92M USD +18.3%
Liabilities, Current 16.8M USD +78.4%
Operating Lease, Liability, Noncurrent 3.02M USD -31%
Other Liabilities, Noncurrent 200K USD
Liabilities 60.8M USD +37.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -134K USD -41.1%
Retained Earnings (Accumulated Deficit) -774M USD -7.29%
Stockholders' Equity Attributable to Parent 73.2M USD +684%
Liabilities and Equity 134M USD +150%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.5M USD -23.8%
Net Cash Provided by (Used in) Financing Activities 25.4M USD
Net Cash Provided by (Used in) Investing Activities -7.82M USD -454%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 41.7M shares +94%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.09M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 34.8M USD +430%
Interest Paid, Excluding Capitalized Interest, Operating Activities 607K USD
Deferred Tax Assets, Valuation Allowance 109M USD +8.66%
Deferred Tax Assets, Gross 109M USD +8.66%
Operating Lease, Liability 4.81M USD -19.5%
Depreciation 700K USD -12.5%
Payments to Acquire Property, Plant, and Equipment 725K USD +233%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52.6M USD -33.7%
Lessee, Operating Lease, Liability, to be Paid 5.85M USD -21.5%
Property, Plant and Equipment, Gross 17.9M USD +6.35%
Operating Lease, Liability, Current 1.79M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 791K USD -49%
Lessee, Operating Lease, Liability, to be Paid, Year One 853K USD -14.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.04M USD -29.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 807K USD +2.02%
Deferred Tax Assets, Operating Loss Carryforwards 78.7M USD +4.18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 823K USD +1.98%
Additional Paid in Capital 847M USD +15.9%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 116K USD -10.1%
Depreciation, Depletion and Amortization 491K USD -25.7%
Share-based Payment Arrangement, Expense 5.94M USD +87.9%
Interest Expense 2.24M USD +315%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%